About
Technology
Issues
FAQ
Search
filter by year
2024 (26)
2023 (1,270)
2022 (4,768)
2021 (5,665)
2020 (5,037)
2010-2019 (29,791)
2000-2009 (13,884)
1990-1999 (6,156)
1980-1989 (3,252)
1970-1979 (1,748)
1960-1969 (910)
1950-1959 (586)
1900-1950 (1,045)
Similar Keywords
cytopenia (2,068)
anemia (73,951)
1-20 of (75,801 documents found)
2008
129
Management of Complications of Prostate Cancer Treatment
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 58, 196-213.
Cite
Citations
Matthew Li (80, 6.9K)
2004
0
ANEMIA DRUG MAY IMPAIR TUMOR CONTROL DURING RADIATION
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 54, 1-2.
Cite
Citations
Matthew Li (80, 6.9K)
2015
4.2K
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine
(
13.9
★★★
), 373, 1803-1813.
Cite
Citations
Matthew Li (80, 6.9K)
2017
3.1K
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine
(
13.9
★★★
), 377, 2531-2544.
Cite
Citations
Matthew Li (80, 6.9K)
2010
4.4K
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
New England Journal of Medicine
(
13.9
★★★
), 362, 2380-2388.
Cite
Citations
Matthew Li (80, 6.9K)
2016
1.5K
Palbociclib and Letrozole in Advanced Breast Cancer
New England Journal of Medicine
(
13.9
★★★
), 375, 1925-1936.
Cite
Citations
Matthew Li (80, 6.9K)
2016
1.5K
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
New England Journal of Medicine
(
13.9
★★★
), 375, 2154-2164.
Cite
Citations
Matthew Li (80, 6.9K)
2020
933
Olaparib for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine
(
13.9
★★★
), 382, 2091-2102.
Cite
Citations
Matthew Li (80, 6.9K)
2018
1.1K
Talazoparib in Patients with Advanced Breast Cancer and a Germline
BRCA
Mutation
New England Journal of Medicine
(
13.9
★★★
), 379, 753-763.
Cite
Citations
Matthew Li (80, 6.9K)
2015
1.5K
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
New England Journal of Medicine
(
13.9
★★★
), 373, 1697-1708.
Cite
Citations
Matthew Li (80, 6.9K)
2012
2.2K
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
New England Journal of Medicine
(
13.9
★★★
), 366, 520-529.
Cite
Citations
Matthew Li (80, 6.9K)
2011
2.2K
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
New England Journal of Medicine
(
13.9
★★★
), 364, 514-523.
Cite
Citations
Matthew Li (80, 6.9K)
2020
816
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
New England Journal of Medicine
(
13.9
★★★
), 382, 610-621.
Cite
Citations
Matthew Li (80, 6.9K)
2019
960
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
New England Journal of Medicine
(
13.9
★★★
), 381, 2391-2402.
Cite
Citations
Matthew Li (80, 6.9K)
2011
2.0K
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
New England Journal of Medicine
(
13.9
★★★
), 364, 2405-2416.
Cite
Citations
Matthew Li (80, 6.9K)
2011
2.1K
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
New England Journal of Medicine
(
13.9
★★★
), 364, 1195-1206.
Cite
Citations
Matthew Li (80, 6.9K)
2021
682
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
New England Journal of Medicine
(
13.9
★★★
), 384, 705-716.
Cite
Citations
Matthew Li (80, 6.9K)
2019
889
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
New England Journal of Medicine
(
13.9
★★★
), 380, 1726-1737.
Cite
Citations
Matthew Li (80, 6.9K)
2018
906
Durable Remissions with Ivosidenib in
IDH1
-Mutated Relapsed or Refractory AML
New England Journal of Medicine
(
13.9
★★★
), 378, 2386-2398.
Cite
Citations
Matthew Li (80, 6.9K)
2008
2.7K
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
New England Journal of Medicine
(
13.9
★★★
), 359, 1116-1127.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.